• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在血管生物反应器中进行的原位冠状动脉支架植入术。

In-culture coronary stenting in an vascular bioreactor.

作者信息

Razzi F, Bobi J, Stijnen M, van Esch J H, Duncker D J, van Steijn V, van Beusekom H M M

机构信息

Division of Experimental Cardiology, Cardiology Department, Erasmus MC University Medical Center, Rotterdam, Netherlands.

Department of Chemical Engineering, Faculty of Applied Sciences, TU Delft, Delft, Netherlands.

出版信息

Front Cardiovasc Med. 2025 Jul 31;12:1565674. doi: 10.3389/fcvm.2025.1565674. eCollection 2025.

DOI:10.3389/fcvm.2025.1565674
PMID:40822006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12350248/
Abstract

BACKGROUND

vascular bioreactors that enable interventions in arteries from slaughterhouse surplus hearts present valuable alternatives to animal models to test cardiovascular stents. However, the knowledge for stent implantation during culture in slaughterhouse coronary arteries is limited. The objective of the study is two-fold: first, to determine culture settings, the time point and optimal conditions for in-culture stent implantation using surplus right coronary arteries (RCAs) from swine with known RCA diameters; and second, to implement the gained insights to culture and stent RCAs obtained from slaughterhouse hearts (unknown diameter).

METHODS

Swine RCAs were mounted, cultured and stented in an vascular bioreactor (VABIO) under conditions of flow and pressure. The bioreactor culture and stenting protocols were optimized using a step wise approach. In Step 1, the RCAs dissected from in-house swine hearts, with known diameters, were cultured until endothelialized as the ideal time point for stenting, and the stent implantation procedure was optimized. In Step 2, the successful stent implantation procedure was repeated in slaughterhouse RCAs. Structural changes of the RCAs were assessed by ultrasound imaging during culture. The morphology of the RCAs at the end of culture was assessed by histology.

RESULTS

The RCAs adapted to the environment, stabilizing their diameter in the range of the diameter after day 3, which was selected as the earliest time point for stenting. Because stent implantations caused mural dissections in the RCAs, visible with ultrasound imaging and confirmed by histology, we developed an external support for the RCA. This was found to be critical for better physiological intravascular pressures and to minimize dissections upon stent implantation. Finally, the stent implantation procedure was successfully replicated in slaughterhouse arteries.

CONCLUSIONS

Our study demonstrates the feasibility of in-culture stent implantation in the VABIO, providing important requirements and useful insights for mimicking stent implantation, for future investigations in slaughterhouse arteries.

摘要

背景

能够对屠宰场剩余心脏的动脉进行干预的血管生物反应器,为测试心血管支架的动物模型提供了有价值的替代方案。然而,关于在屠宰场冠状动脉培养过程中进行支架植入的知识有限。本研究的目的有两个:第一,确定使用已知右冠状动脉(RCA)直径的猪的剩余右冠状动脉进行培养内支架植入的培养设置、时间点和最佳条件;第二,将获得的见解应用于培养和植入从屠宰场心脏获得的RCA(直径未知)。

方法

将猪RCA安装在血管生物反应器(VABIO)中,在流动和压力条件下进行培养和支架植入。采用逐步方法优化生物反应器培养和支架植入方案。在步骤1中,从内部猪心脏解剖出已知直径的RCA,培养至内皮化作为支架植入的理想时间点,并优化支架植入程序。在步骤2中,在屠宰场RCA中重复成功的支架植入程序。在培养过程中通过超声成像评估RCA的结构变化。培养结束时通过组织学评估RCA的形态。

结果

RCA适应了环境,在第3天后其直径稳定在一定范围内,该时间点被选为最早的支架植入时间点。由于支架植入导致RCA出现壁内夹层,超声成像可见并经组织学证实,我们为RCA开发了外部支撑。发现这对于获得更好的生理血管内压力以及最小化支架植入时的夹层至关重要。最后,支架植入程序在屠宰场动脉中成功复制。

结论

我们的研究证明了在VABIO中进行培养内支架植入的可行性,为模拟支架植入提供了重要要求和有用见解,以便未来对屠宰场动脉进行研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/d27166dd0fcc/fcvm-12-1565674-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/0c26fb18d554/fcvm-12-1565674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/b576b5202948/fcvm-12-1565674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/9d384c6e914c/fcvm-12-1565674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/764975e32350/fcvm-12-1565674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/312e27b6b93a/fcvm-12-1565674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/11de8ecbac9f/fcvm-12-1565674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/d2db830c1472/fcvm-12-1565674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/7e46bf03cd03/fcvm-12-1565674-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/dad6ecf854f7/fcvm-12-1565674-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/98a7b8c4a655/fcvm-12-1565674-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/d27166dd0fcc/fcvm-12-1565674-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/0c26fb18d554/fcvm-12-1565674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/b576b5202948/fcvm-12-1565674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/9d384c6e914c/fcvm-12-1565674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/764975e32350/fcvm-12-1565674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/312e27b6b93a/fcvm-12-1565674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/11de8ecbac9f/fcvm-12-1565674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/d2db830c1472/fcvm-12-1565674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/7e46bf03cd03/fcvm-12-1565674-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/dad6ecf854f7/fcvm-12-1565674-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/98a7b8c4a655/fcvm-12-1565674-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6234/12350248/d27166dd0fcc/fcvm-12-1565674-g011.jpg

相似文献

1
In-culture coronary stenting in an vascular bioreactor.在血管生物反应器中进行的原位冠状动脉支架植入术。
Front Cardiovasc Med. 2025 Jul 31;12:1565674. doi: 10.3389/fcvm.2025.1565674. eCollection 2025.
2
Intravascular brachytherapy for peripheral vascular disease.血管内近距离放射治疗外周血管疾病。
Cochrane Database Syst Rev. 2014 Jan 8;2014(1):CD003504. doi: 10.1002/14651858.CD003504.pub2.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Routine intraoperative ureteric stenting for kidney transplant recipients.常规术中输尿管置管术用于肾移植受者。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD004925. doi: 10.1002/14651858.CD004925.pub4.
8
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation.足细胞蛋白是人类子宫内膜上皮细胞接受胚胎植入的关键负调控因子。
Hum Reprod. 2021 Apr 20;36(5):1353-1366. doi: 10.1093/humrep/deab032.

本文引用的文献

1
Intravascular Imaging for Guiding In-Stent Restenosis and Stent Thrombosis Therapy.血管内影像学在指导支架内再狭窄和支架内血栓形成治疗中的应用。
J Am Heart Assoc. 2022 Nov 15;11(22):e026492. doi: 10.1161/JAHA.122.026492. Epub 2022 Nov 3.
2
Engineering Vascular Bioreactor Systems to Closely Mimic Physiological Forces .工程化血管生物反应器系统以模拟生理力
Tissue Eng Part B Rev. 2023 Jun;29(3):232-243. doi: 10.1089/ten.TEB.2022.0158. Epub 2022 Dec 8.
3
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.
了解药物涂层球囊药物传递和保留的机制。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221119559. doi: 10.1177/10742484221119559.
4
3D Printed Bioreactor Enabling the Pulsatile Culture of Native and Angioplastied Large Arteries.3D打印生物反应器实现天然和血管成形术后大动脉的搏动性培养
Front Cardiovasc Med. 2022 Jun 21;9:864580. doi: 10.3389/fcvm.2022.864580. eCollection 2022.
5
Atherosclerosis: Known and unknown.动脉粥样硬化:已知与未知
Pathol Int. 2022 Mar;72(3):151-160. doi: 10.1111/pin.13202. Epub 2022 Jan 25.
6
The Development of an Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices.一种用于评估心血管血管内装置急性动脉药物滞留的流动系统的开发。
Front Med Technol. 2021 Jun 10;3:675188. doi: 10.3389/fmedt.2021.675188. eCollection 2021.
7
Agarose-based spheroid culture enhanced stemness and promoted odontogenic differentiation potential of human dental follicle cells in vitro.琼脂糖球状体培养增强了人牙囊细胞的干性并促进了其成牙分化潜能。
In Vitro Cell Dev Biol Anim. 2021 Jun;57(6):620-630. doi: 10.1007/s11626-021-00591-5. Epub 2021 Jul 1.
8
An ex vivo physiologic and hyperplastic vessel culture model to study intra-arterial stent therapies.一种用于研究动脉内支架治疗的离体生理和增生性血管培养模型。
Biomaterials. 2021 Aug;275:120911. doi: 10.1016/j.biomaterials.2021.120911. Epub 2021 May 29.
9
Coronary Artery Disease as the Cause of Sudden Cardiac Death Among Victims < 50 Years of Age.冠状动脉疾病是 50 岁以下猝死者的病因。
Am J Cardiol. 2021 May 15;147:33-38. doi: 10.1016/j.amjcard.2021.02.012. Epub 2021 Feb 20.
10
Comparison of in Vascular Bioreactors and In Vivo Models of Degradation and Cellular Response of Mg-Zn-Mn Stents.镁锌锰支架在血管生物反应器和体内模型中的降解及细胞反应比较。
Ann Biomed Eng. 2021 Jun;49(6):1551-1560. doi: 10.1007/s10439-020-02699-3. Epub 2021 Jan 6.